This can lower your metabolic rate and lead to physical weakness
Furthermore, excess body weight is also linked to an increased risk of type 2 diabetes, cardiovascular disease, and other metabolic disorders, making obesity a significant public health concern
Effect of Dimethyl Fumarate vs Interferon beta-1a in patients with Pediatric-Onset multiple sclerosis: the CONNECT Randomized Clinical Trial
Because semaglutide, tirzepatide, and dulaglutide produce similar results in the context of type 2 diabetes and weight loss, the choice regarding which medication to prescribe comes down to preference, patient tolerance, cost, administration (oral or injectable), and patient responsiveness
and (c) FDA-approved products containing semaglutide are available